PLATINUM INVESTMENT MANAGEMENT LTD - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 73 filers reported holding OVID THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$2,462,000
-4.5%
766,9010.0%0.07%
-5.5%
Q3 2021$2,577,000
+66.0%
766,901
+93.2%
0.07%
+102.8%
Q2 2021$1,552,000
-2.7%
396,8700.0%0.04%0.0%
Q1 2021$1,595,000
+73.9%
396,8700.0%0.04%
+71.4%
Q4 2020$917,000
-31.6%
396,870
+70.0%
0.02%
-36.4%
Q3 2020$1,340,000
-39.7%
233,413
-22.6%
0.03%
-35.3%
Q2 2020$2,223,000
+94.8%
301,589
-21.2%
0.05%
+75.9%
Q1 2020$1,141,000
-10.2%
382,935
+25.1%
0.03%
+16.0%
Q4 2019$1,271,000
+202.6%
306,146
+136.2%
0.02%
+177.8%
Q3 2019$420,000129,6000.01%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders